Nick van Es

11.5k total citations · 7 hit papers
132 papers, 6.7k citations indexed

About

Nick van Es is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Emergency Medical Services. According to data from OpenAlex, Nick van Es has authored 132 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Internal Medicine, 71 papers in Cardiology and Cardiovascular Medicine and 34 papers in Emergency Medical Services. Recurrent topics in Nick van Es's work include Venous Thromboembolism Diagnosis and Management (110 papers), Central Venous Catheters and Hemodialysis (34 papers) and Atrial Fibrillation Management and Outcomes (31 papers). Nick van Es is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (110 papers), Central Venous Catheters and Hemodialysis (34 papers) and Atrial Fibrillation Management and Outcomes (31 papers). Nick van Es collaborates with scholars based in Netherlands, Italy and United States. Nick van Es's co-authors include Harry R. Büller, Marcello Di Nisio, Saskia Middeldorp, Michiel Coppens, Sam Schulman, Marc Carrier, Frits I. Mulder, Jeffrey I. Weitz, Ludo F.M. Beenen and Patrick M. Bossuyt and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Nick van Es

122 papers receiving 6.6k citations

Hit Papers

Edoxaban for the Treatment of Cancer-Associated Venous Th... 2014 2026 2018 2022 2017 2020 2016 2014 2020 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
    2017 1.1k citations Nick van Es, Marc Carrier et al. profile →
  2. Incidence of venous thromboembolism in hospitalized patients with COVID‐19
    2020 1.0k citations Saskia Middeldorp, Michiel Coppens et al. Journal of Thrombosis and Haemostasis profile →
  3. Deep vein thrombosis and pulmonary embolism
    2016 606 citations Marcello Di Nisio, Nick van Es et al. profile →
  4. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials
    2014 581 citations Nick van Es, Michiel Coppens et al. Blood profile →
  5. Venous thromboembolism in cancer patients: a population-based cohort study
    2020 399 citations Frits I. Mulder, Erzsébet Horváth–Puhó et al. Blood profile →
  6. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts
    2018 230 citations Ingrid Pabinger, Nick van Es et al. profile →
  7. The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
    2019 204 citations Frits I. Mulder, Pieter W. Kamphuisen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nick van Es Netherlands 32 4.8k 3.0k 1.2k 1.2k 1.1k 132 6.7k
Philip Wells Canada 22 4.6k 1.0× 3.1k 1.0× 860 0.7× 1.5k 1.3× 484 0.4× 34 5.8k
Marc Carrier Canada 51 8.1k 1.7× 5.6k 1.9× 2.5k 2.1× 2.3k 2.0× 525 0.5× 388 11.0k
Agnes Lee Canada 43 7.4k 1.6× 4.9k 1.6× 2.7k 2.3× 2.1k 1.8× 430 0.4× 137 9.4k
Paolo Simioni Italy 51 5.8k 1.2× 3.6k 1.2× 1.2k 1.0× 2.2k 1.9× 750 0.7× 415 12.3k
Cihan Ay Austria 57 7.6k 1.6× 4.7k 1.6× 1.8k 1.5× 2.0k 1.7× 441 0.4× 384 12.8k
Michael B. Streiff United States 53 5.1k 1.1× 2.6k 0.8× 1.8k 1.5× 2.2k 1.9× 268 0.2× 266 8.2k
Olivier Sanchez France 40 5.1k 1.1× 3.3k 1.1× 743 0.6× 1.2k 1.0× 385 0.3× 204 7.6k
Ismaı̈l Elalamy France 32 1.8k 0.4× 1.3k 0.4× 263 0.2× 884 0.8× 1.3k 1.2× 241 4.9k
Michiel Coppens Netherlands 29 2.0k 0.4× 1.8k 0.6× 235 0.2× 600 0.5× 894 0.8× 134 4.5k
Robert D. McBane United States 44 3.5k 0.7× 3.4k 1.1× 687 0.6× 2.0k 1.7× 189 0.2× 262 6.7k

Countries citing papers authored by Nick van Es

Since Specialization
Citations

This map shows the geographic impact of Nick van Es's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick van Es with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick van Es more than expected).

Fields of papers citing papers by Nick van Es

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick van Es. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick van Es. The network helps show where Nick van Es may publish in the future.

Co-authorship network of co-authors of Nick van Es

This figure shows the co-authorship network connecting the top 25 collaborators of Nick van Es. A scholar is included among the top collaborators of Nick van Es based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick van Es. Nick van Es is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moik, Florian, Erzsébet Horváth–Puhó, Cihan Ay, et al.. (2025). Arterial and venous thromboembolic events in patients with cancer treated with targeted therapies: a population-based cohort study. EClinicalMedicine. 87. 103440–103440.
2.
Cnossen, Marjon H., Nick van Es, Paul L. den Exter, et al.. (2025). Health-related quality of life in rare bleeding disorders: results from the Rare Bleeding Disorders in the Netherlands study. Research and Practice in Thrombosis and Haemostasis. 9(5). 102961–102961.
3.
Haaps, Thijs F. van, Ruben W.J. van Helden, Hugo J. Albers, et al.. (2025). Blood-perfused Vessels-on-Chips stimulated with patient plasma recapitulate endothelial activation and microthrombosis in COVID-19. Lab on a Chip. 25(7). 1787–1800. 2 indexed citations
4.
Willems, Sara M., Marjon H. Cnossen, Nick van Es, et al.. (2025). Bleeding symptoms in persons with rare bleeding disorders and a heterozygous genotype: data from the Rare Bleeding Disorders in the Netherlands study. Journal of Thrombosis and Haemostasis. 23(6). 1787–1799. 1 indexed citations
5.
Geest, Marleen van, Robert Dagil, Tobias Gustavsson, et al.. (2025). Targeting Oncofoetal Chondroitin Sulphate Allows Identification of Tumour‐Derived Extracellular Vesicles. Journal of Extracellular Vesicles. 14(6). e70106–e70106.
6.
Es, Nick van, et al.. (2024). Elevated levels of citrullinated fibrinogen in patients with cancer. SHILAP Revista de lepidopterología. 5(1). 136–140. 2 indexed citations
7.
Simons, Annet, Marjan M. Weiss, Sanna R. Rijpma, et al.. (2024). Targeted exome analysis in patients with rare bleeding disorders: data from the Rare Bleeding Disorders in the Netherlands study. Research and Practice in Thrombosis and Haemostasis. 8(4). 102477–102477. 4 indexed citations
8.
Takada, Toshihiko, Floris T.M. Bosch, Andrea Marshall, et al.. (2024). Risk of Recurrent Venous Thromboembolism in Patients with Cancer: An Individual Patient Data Meta-analysis and Development of a Prediction Model. Thrombosis and Haemostasis. 125(6). 589–596. 2 indexed citations
9.
Haaps, Thijs F. van, Hugo Ten Cate, Marieke J. H. A. Kruip, et al.. (2024). The effect of current antithrombotic therapy on mortality in nursing home residents with COVID-19: a multicentre retrospective cohort study. Age and Ageing. 53(5). 1 indexed citations
10.
Hart, Christina, Nick van Es, & Minna Voigtlaender. (2024). Primary Prevention of Cancer-Associated Thrombosis: Current Perspectives. Hämostaseologie. 45(2). 127–138. 1 indexed citations
11.
Bosch, Floris T.M., Elena Campello, Frits I. Mulder, et al.. (2023). Contact system and intrinsic pathway activation in patients with advanced pancreatic cancer: a prospective cohort study. Journal of Thrombosis and Haemostasis. 21(10). 2863–2872. 4 indexed citations
12.
Lee, Jenny, Nick van Es, Toshihiko Takada, et al.. (2023). Covariate-specific ROC curve analysis can accommodate differences between covariate subgroups in the evaluation of diagnostic accuracy. Journal of Clinical Epidemiology. 160. 14–23. 9 indexed citations
13.
Es, Nick van, Raffaele De Caterina, & Jeffrey I. Weitz. (2023). Reversal agents for current and forthcoming direct oral anticoagulants. European Heart Journal. 44(20). 1795–1806. 21 indexed citations
14.
Favresse, Julien, Michaël Hardy, Jonathan Douxfils, et al.. (2022). D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review. Diagnostics. 12(11). 2770–2770. 3 indexed citations
15.
16.
Maraveyas, Anthony, Noémie Kraaijpoel, George Bozas, et al.. (2021). The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study. Journal of Thrombosis and Haemostasis. 19(11). 2791–2800. 7 indexed citations
17.
Kraaijpoel, Noémie, Marc Carrier, Grégoire Le Gal, et al.. (2020). Diagnostic accuracy of three ultrasonography strategies for deep vein thrombosis of the lower extremity: A systematic review and meta-analysis. PLoS ONE. 15(2). e0228788–e0228788. 26 indexed citations
18.
Middeldorp, Saskia, Michiel Coppens, Thijs F. van Haaps, et al.. (2020). Incidence of venous thromboembolism in hospitalized patients with COVID‐19. Journal of Thrombosis and Haemostasis. 18(8). 1995–2002. 1017 indexed citations breakdown →
19.
Es, Nick van, Grégoire Le Gal, Hans-Martin Otten, et al.. (2017). Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis. BMJ Open. 7(6). e015562–e015562. 11 indexed citations
20.
Es, Nick van, Michiel Coppens, Sam Schulman, Saskia Middeldorp, & Harry R. Büller. (2014). Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood. 124(12). 1968–1975. 581 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip Wells Breakdown of academic impact, for papers by Marc Carrier Breakdown of academic impact, for papers by Agnes Lee Breakdown of academic impact, for papers by Paolo Simioni Breakdown of academic impact, for papers by Cihan Ay Breakdown of academic impact, for papers by Michael B. Streiff Breakdown of academic impact, for papers by Olivier Sanchez Breakdown of academic impact, for papers by Ismaı̈l Elalamy Breakdown of academic impact, for papers by Michiel Coppens Breakdown of academic impact, for papers by Robert D. McBane
Rankless by CCL
2026